Octagon Capital Advisors LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001839435

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2024 · 41 positions · Total reported value $611.01M · Top-10 concentration 67.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 65.5% · 2 new · 14 cut · 3 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -23.3% · vs SPY -25.4% · Prev Value $1.11B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -9.9% · vs SPY -12.0% · Latest Value $750.61M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2024 13F filing, Octagon Capital Advisors LP disclosed 41 equity positions with a combined reported value of $611.01M. The filing implies a focused portfolio: its ten largest positions account for 67.2% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2024 were APLS ($86.72M), VRNA ($52.80M), GPCR ($52.58M). By sector, the heaviest allocations are Health Care 62.5%, Industrials 1.4%. Versus the prior quarter, allocation shifted toward Other (+8.6pp) and away from Industrials (-0.5pp), Health Care (-8.1pp).

Versus the prior quarter, Octagon Capital Advisors LP opened 2 new positions, trimmed 14 and fully exited 3, a turnover rate of 65.5% of positions. The portfolio's overlap with the prior quarter was 67% of names.

The largest new positions opened in Q3 2024 were COGT ($14.09M), PHVS ($11.49M), HELP ($4.35M).

Of the 3 positions fully exited versus the prior quarter, the largest were TERN ($9.29M), ANTX ($6.92M), AKRO ($6.65M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2024)

  • COGT COGENT BIOSCIENCES INC · $14.09M
  • PHVS PHARVARIS N V · $11.49M
  • HELP CYBIN INC · $4.35M
  • UNCY UNICYCIVE THERAPEUTICS INC · $3.49M
  • BDTX BLACK DIAMOND THERAPEUTICS I · $2.58M
  • NUVBWS NUVATION BIO INC · $715.25K
  • NGNE NEUROGENE INC · $629.40K

Fully Exited (vs previous quarter)

  • TERN TERNS PHARMACEUTICALS INC · prev qtr: $9.29M
  • ANTX AN2 THERAPEUTICS INC · prev qtr: $6.92M
  • AKRO AKERO THERAPEUTICS INC · prev qtr: $6.65M
  • JSPR JASPER THERAPEUTICS INC · prev qtr: $6.53M
  • CYBN CYBIN INC · prev qtr: $5.04M
  • SLN SILENCE THERAPEUTICS PLC · prev qtr: $3.34M
  • PSTX POSEIDA THERAPEUTICS INC · prev qtr: $2.15M
  • ELEV ELEVATION ONCOLOGY INC · prev qtr: $2.02M

Insider Transactions (Form 4)

Latest Octagon Capital Advisors LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Octagon Capital Advisors LP is an SEC-registered 13F filer based in New York, NY, United States. As of Q3 2026 it reported 26 US equity positions with a combined value of $750.61M. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-118554 (status: Approved), registered 2020-04-27
  • Regulatory AUM (Form ADV): $1.18B as of 2026-03-20
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 4 private funds, of which 1 hedge funds
  • Website: octagoninvestments.com

Portfolio Structure

  • 26 positions · $750.61M reported value (Q3 2026)
  • Top 10 holdings = 82.5% of reported value
  • Largest position: DNTH (DIANTHUS THERAPEUTICS INC) at 19.8%
  • Average position size: $28.87M

Sector Tilt

  • Health Care 99.6%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 2 new, 1 added, 14 reduced, 3 exited
  • 9 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 62.5%
Other 36.1%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 3.01M $86.72M 14.19%
14.19%
Add
2 1.84M $52.80M 8.64%
8.64%
Reduce
3 1.20M $52.58M 8.61%
8.61%
Add
4 1.75M $47.82M 7.83%
7.83%
Hold
5 1.98M $46.45M 7.60%
7.60%
Add
6 2.01M $32.17M 5.26%
5.26%
Reduce
7 12.17M $27.87M 4.56%
4.56%
Add
8 1.11M $23.00M 3.77%
3.77%
Add
9 2.42M $21.10M 3.45%
3.45%
Hold
10 870.00K $19.79M 3.24%
3.24%
Add
11 1.42M $18.99M 3.11%
3.11%
Reduce
12 250.00K $18.25M 2.99%
2.99%
Hold
13 3.02M $17.17M 2.81%
2.81%
Add
14 1.30M $14.09M 2.31%
2.31%
New
15 552.00K $14.05M 2.30%
2.30%
Reduce
16 620.47K $11.49M 1.88%
1.88%
New
17 262.73K $9.44M 1.54%
1.54%
Reduce
18 4.57M $9.19M 1.50%
1.50%
Hold
19 9.19M $9.06M 1.48%
1.48%
Hold
20 11.20M $9.06M 1.48%
1.48%
Add
21 1.09M $8.74M 1.43%
1.43%
Hold
22 130.00K $7.48M 1.22%
1.22%
Reduce
23 600.00K $7.27M 1.19%
1.19%
Hold
24 4.26M $6.69M 1.10%
1.10%
Hold
25 2.39M $5.21M 0.85%
0.85%
Hold
26 2.58M $4.97M 0.81%
0.81%
Hold
27 489.60K $4.35M 0.71%
0.71%
New
28 2.25M $3.83M 0.63%
0.63%
Hold
29 8.56M $3.49M 0.57%
0.57%
New
30 376.12K $3.22M 0.53%
0.53%
Hold
31 250.00K $2.61M 0.43%
0.43%
Hold
32 594.00K $2.58M 0.42%
0.42%
New
33 400.00K $2.37M 0.39%
0.39%
Hold
34 992.00K $1.87M 0.31%
0.31%
Hold
35 666.83K $1.14M 0.19%
0.19%
Reduce
36 465.44K $972.77K 0.16%
0.16%
Hold
37 312.34K $715.25K 0.12%
0.12%
New
38 176.00K $638.88K 0.10%
0.10%
Hold
39 15.00K $629.40K 0.10%
0.10%
New
40 292.00K $586.92K 0.10%
0.10%
Hold
41 120.00K $542.40K 0.09%
0.09%
Reduce

FAQ

What did Octagon Capital Advisors LP buy in 2024-Q3?

In its 2024-Q3 13F filing, Octagon Capital Advisors LP reported 41 equity positions worth $611.01M in aggregate; its largest disclosed positions were APLS ($86.72M), VRNA ($52.80M), GPCR ($52.58M).

How large is Octagon Capital Advisors LP's portfolio?

Octagon Capital Advisors LP reported $611.01M of long equity holdings across 41 positions as of 2024-Q3. Top-10 holdings account for 67.2% of reported value.

What is Octagon Capital Advisors LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/octagon-capital-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →